ArchivesMagazine - 11 Sep 2025Animal vaccine maker Genus chalks up another major milestone 2025 progress continues with strong results and a major collaboration 11 September 2025|News|by Ian Conway Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Worse-than-expected US payrolls data puts ball in Federal Reserve’s court Watches of Switzerland update raises questions over full-year outlook > Issue: 11 Sep 2025 - Page 9 | Contents Next: Watches of Switzerland update raises questions over full-year outlook Previous: Worse-than-expected US payrolls data puts ball in Federal Reserve’s court Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Ian Conway Issue Contents Ask Rachel What happens if I go over my pension tax relief limit? Dan Coatsworth New data shows how retail investors are positioning portfolios Editor's View How a jobs report broke the looking glass Feature Stocks with a lasting edge: How companies can sustain a competitive advantage Hedge fund filings reveal significant shifts in holdings in the second quarter Dull? The diversified financials sector is anything but Great Ideas Foresight Group has unappreciated growth and yield attractions Morgan Advanced Materials starts a new chapter under CEO Caby Why Gear4music is delivering a tune to our liking News Worse-than-expected US payrolls data puts ball in Federal Reserve’s court Why Musk’s $1 trillion Tesla pay deal will spark debate Watches of Switzerland update raises questions over full-year outlook Animal vaccine maker Genus chalks up another major milestone Personal Finance Will higher annuity rates transform the retirement income market? Week Ahead Can Next grind out yet another upgrade? FedEx will offer a barometer of the economy when it reports earnings
